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(9). The TMB-2–producing A. soli 
strain that we isolated came from a 
blood culture, indicating that A. soli 
is a potential cause of bloodstream in-
fections or bacteremia. A. soli has also 
been detected in lice and keds of do-
mestic animals (10), indicating that A. 
soli may inhabit natural environments 
and that injuries and bites by arthro-
pods might present a risk for invasive 
infections. Isolates of Acinetobacter 
species, particularly those recovered 
from blood culture, should be identi-
fied to species type to enable further 
evaluation of the clinical significance 
of carbapenem-resistant A. soli strains.
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Spread of  
Vaccinia Virus to 
Cattle Herds,  
Argentina, 2011
To the Editor: Since 1999, sev-
eral zoonotic outbreaks of vaccinia 
virus (VACV) infection have been re-
ported in cattle and humans in rural 
areas of Brazil. The infections have 
caused exanthematous lesions on cows 
and persons who milk them, and thus 
are detrimental to the milk industry 
and public health services (1,2). In 
Brazil during the last decade, VACV 
outbreaks have been detected from 
the north to the extreme south of the 
country (1–4). Because Brazil shares 
extensive boundaries with other South 
American countries, humans and cattle 
on dairy and beef-producing farms in 
those countries may be at risk of expo-
sure to VACV. To determine if VACV 
has spread from Brazil to Argentina, we 
investigated the presence of VACV in 
serum samples from cattle in Argentina.
During 2011, we obtained serum 
samples from 100 animals (50 dairy 
and 50 beef cattle) on farms in Cór-
doba, Corrientes, Entre Ríos, and San-
ta Fe Provinces in Argentina (online 
Technical Appendix, panel A, http://
wwwnc.cdc.gov/EID/article/20/9/14-
0154-Techapp1.pdf). No VACV cases 
had been reported in humans or cattle 
in these provinces. However, Corrien-
tes Province borders the Brazilian state 
of Rio Grande do Sul, where VACVs 
(Pelotas 1 and Pelotas 2 viruses) were 
isolated during an outbreak affecting 
horses in 2008 (2).
To determine the presence of neu-
tralizing antibodies in the serum sam-
ples, we used an orthopoxvirus 70% 
plaque-reduction neutralization test as 
described (4). On the basis of previ-
ous studies that detected viral DNA 
in serum samples (4–6), we used real-
time PCR to amplify the highly con-
served orthopoxvirus vaccinia growth 
factor (vgf) gene DNA (P.A. Alves, 
unpub. methods).
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To amplify the hemagglutinin 
(HA) gene DNA from the serum 
samples, we used real-time PCR with 
primers as described by de Souza 
Trindade et al. 2008 (7). The HA PCR 
products were directly sequenced in 
both orientations by using specific 
primers and capillary electrophoresis 
(Genetic Analyzer 3130; Applied Bio-
systems, Grand Island, NY, USA). We 
used ClustalW (http://www.clustal.
org) and MEGA4 software (http://
megasoftware.net/) to align nucleotide 
sequences and construct a phyloge-
netic tree (neighbor-joining method, 
1,000 bootstraps) from the obtained 
HA fragment.
Of the 50 dairy cattle samples, 
4 (8.0%) had neutralizing antibod-
ies against orthopoxvirus; of these, 
3 (75.0%) had titers of 100 neutral-
izing units (NU)/mL, and 1 (25.0%) 
had a titer of 400 NU/mL. Of the 50 
beef cattle, 8 (16.0%) had antibodies 
to orthopoxvirus, 1 (12.5%) of which 
had a titer of 800 NU/mL. Most of 
the positive samples were from cattle 
in Corrientes and Entre Ríos Provinc-
es (Table).
Of the 100 serum samples, 5 (3 
from beef and 2 from dairy cattle) 
were positive for vgf by real-time 
PCR. HA DNA was amplified from 2 
of the 3 vgf PCR–positive beef cattle 
samples; plaque-reduction neutraliza-
tion test results were also positive for 
the 2 samples (Table). 
Alignment of the HA fragment 
nucleotide sequence of the isolates 
from Argentina showed that the se-
quence was highly similar to that of 
the homologous gene of VACV iso-
lates from Brazil. Furthermore, the se-
quences showed a signature deletion 
that is also present in the sequences 
of VACV isolates from Brazil. Com-
pared with sequences for other VACV 
isolates, those from Argentina had 2 
polymorphisms (online Technical Ap-
pendix, panel C). The HA sequences 
from the isolates from Argentina dem-
onstrated 100% identity among them-
selves and exhibited higher identity 
with group 1 (98.2% identity) versus 
group 2 (93.6% identity) isolates from 
Brazil (online Technical Appendix, 
panel D). In the phylogenetic tree 
based on the HA nucleotide sequences 
(online Technical Appendix, panel B), 
the VACVs from Argentina clustered 
with several group 1 VACVs detected 
during outbreaks in Brazil.
Although no outbreaks of exan-
thematous VACV infection have been 
described in cattle or humans in Ar-
gentina, we detected neutralizing an-
tibodies against orthopoxvirus and de-
tected VACV DNA in serum samples 
from cattle in the country. Most of the 
seropositive samples were from cattle 
in Entre Ríos Province, which shares a 
border with Uruguay, and Corrientes 
Province, which shares a border with 
Rio Grande do Sul State in Brazil, 
where Pelotas VACVs have been iso-
lated (2). 
We believe that the seropositive 
cattle in this study may have been ex-
posed to VACV, the only orthopoxvi-
rus known to be circulating in South 
America (1–4,8–10). Despite vet-
erinary surveillance efforts of border 
control organizations, VACV control 
may be hampered by the circulation of 
infected rural workers and the misdi-
agnosis of VACV infection; misdiag-
noses occur because VACV lesions re-
semble those of other exanthematous 
diseases. Moreover, peridomestic ro-
dents have been hypothesized to act as 
VACV hosts, and could facilitate the 
spread of VACV in border areas (10). 
In addition, we could not rule out the 
circulation of autochthonous VACV 
in Argentina, but this is a less likely 
explanation. Our findings suggest that 
cattle herds in areas of Argentina near 
the border with Brazil may be exposed 
to VACV from Brazil and, thus, may 
be at risk for VACV infection. Further 
research is needed to determine the 
risk factors for VACV infection and 
to assess the circulation of VACV in 
South America
Acknowledgments
We thank João Rodrigues dos Santos, 
Ângela Sana Lopes, Ilda Gama, and col-
leagues from the Laboratório de Vírus for 
their excellent technical support. 
Financial support was provided by 
the Conselho Nacional de Desenvolvi-
mento Científico e Tecnológico (CNPq), 
Coordenação de Aperfeiçoamento de Pes-
soal de Nível Superior (CAPES), Funda-
ção de Amparo à Pesquisa do Estado de 
Minas Gerais (FAPEMIG), and Ministério 
da Agricultura, Pecuária e Abastecimento 
(MAPA). A.P.M. F.-L. was the recipient of 
a fellowships from CAPES, and E.G.K., 
C.A.B., G.S.T., and P.C.P.F. were recipi-
ents of fellowships from CNPq.
 
Table.	Diagnosis	of	Orthopoxvirus infection	in	beef	and	dairy	cattle	during	a	study	of	the	spread	of	vaccinia	virus	to	cattle	herds,	
Argentina,	2011* 
Province Cattle	type 
No.	farms 
sampled 
No.	serum	
samples	
tested 
No.	positive	samples,	by	level	of	NU/mL	
against orthopoxvirus† 
 No.	(%)	positive	by	real-time 
PCR 
100 200 400 800 Total	(%) vgf HA 
Córdoba Dairy 1 25 0 0 1 0 1	(4.0)  2	(8.0) 0 
Santa	Fe Dairy 1 25 3 0 0 0 3	(12.0)  0 0 
Corrientes Beef >2‡ 8 0 1 1 0 2	(25.0)  1	(12,5)§ 1	(12,5)§ 
Entre	Ríos Beef 5 42 2 2 1 1 6	(14.3)  2	(4,8) 1	(2,4)§ 
Total Dairy	and	beef >9 100 5 3 3 1 12	(12.0)  5	(5.0) 2	(2.0) 
*HA,	hemagglutinin	gene	DNA;	NU,	serum	dilution	at	which	70%	plaque	reduction	per	mL	occurs;	vgf,	orthopoxvirus	vaccinia	growth	factor	gene	DNA. 
†Determined by plaque-reduction	neutralization	test. 
‡Samples	were	obtained	from	several	farms	in	Corrientes	Province. 
§Animal	was	also	positive	by	plaque-reduction	neutralization	test. 
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Cerebellitis  
Associated  
with Influenza 
A(H1N1)pdm09, 
United States, 2013
To the Editor: Central nervous 
system (CNS) manifestations of in-
fluenza are uncommon, especially in 
adults (1,2), and influenza-associated 
cerebellitis is exceedingly rare: 8 cases 
have been reported (3–7; online Tech-
nical Appendix). We describe a case 
of cerebellitis caused by influenza 
A(H1N1)pdm09 in an adult woman.
The 37-year-old female patient 
who sought medical care in Florida, 
United States, on January 5, 2013, de-
scribed a 4-day history of intermittent 
fever of 38.5°C, generalized fatigue, 
diffuse headache, mild nonproductive 
cough, 3 episodes of vomiting, and 
decreased oral intake. On January 4, 
she experienced acute onset of ataxia 
and dysarthric speech with slurred 
pronunciation. She reported no con-
tact with sick persons, recent travel, 
or exposure to pets or birds. She had a 
medical history of asthma since child-
hood, controlled by using montelukast 
tablets and inhaled steroids. The pa-
tient denied having ever received an 
influenza vaccination.
The patient appeared ill; her oral 
temperature was elevated at 38.3°C, 
but other vital signs were within nor-
mal limits (blood pressure 109/70 mm 
Hg; pulse rate 88 beats/minute; respira-
tory rate 15 breaths per minute; and ox-
ygen saturation 98% at room air). Mu-
cosal membranes appeared normal. No 
neck stiffness or palpable lymph nodes 
were noted. Results of  heart examina-
tion were normal. Lungs were clear 
to auscultation, and the abdomen was 
soft, indicating no hepatosplenomegaly 
or palpable masses. No rash was seen. 
The neurologic examination revealed 
normal mental status but moderate 
ataxic dysarthria. Her cranial nerves 
were intact, and motor strength was 
5/5 throughout. Results of a sensory 
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How to Correctly Remove a Tick
Grasp the tick firmly and as closely to the skin as possible. With a steady motion, pull the tick’s body away from the skin. Do not be alarmed if the tick’s mouthparts remain in the skin. Cleanse the area with an antiseptic.
